The Cell Surface Markers Market forecast indicates a robust compound annual growth rate (CAGR) driven by the explosive development of cell and gene therapies, most notably CAR-T cell therapies and immune checkpoint inhibitors. These breakthrough treatments rely fundamentally on the precise identification and quantification of specific cell surface markers, such as PD-1 and CD19, for...